Insider · CIK 0002045377
Nelson Sun
Files at AARD (Aardvark Therapeutics, Inc.). First filing Feb 19, 2025, latest Sep 11, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AARD: Aardvark Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | Aardvark Therapeutics, Inc. | $395k 76,754 shares | -68% | - | |
| 36Weak | Aardvark Therapeutics, Inc. | $43k 3,000 shares | +3% | +123% from low-10% from high | |
| 48Moderate | Aardvark Therapeutics, Inc. | $48k 6,000 shares | +6% | +13% from low-54% from high | |
| 51Moderate | Aardvark Therapeutics, Inc. | $160k 10,000 shares | +11% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | AARD Aardvark Therapeutics, Inc. | SOpen-market sale Common Stock, par value $0.00001 per share10b5-1 | -14,754 | $5.00 | $74k | 97,475 | 31 d ago |
| Sep 11, 2026 | AARD Aardvark Therapeutics, Inc. | SOpen-market sale Common Stock, par value $0.00001 per share10b5-1 | -62,000 | $5.18 | $321k | 35,475 | 31 d ago |
| Dec 11, 2025 | AARD Aardvark Therapeutics, Inc. | POpen-market purchase Common Stock | +3,000 | $14.40 | $43k | 108,484 | Dec 12, 2025 |
| Sep 9, 2025 | AARD Aardvark Therapeutics, Inc. | POpen-market purchase Common Stock | +6,000 | $8.07 | $48k | 105,484 | Sep 10, 2025 |
| Jun 11, 2025 | AARD Aardvark Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +209,826 | $0.00 | $0 | 209,826 | Jun 13, 2025 |
| Feb 14, 2025 | AARD Aardvark Therapeutics, Inc. | CConversion Common Stock | +7,001 | - | - | 89,484 | Feb 19, 2025 |
| Feb 14, 2025 | AARD Aardvark Therapeutics, Inc. | POpen-market purchase Common Stock | +10,000 | $16.00 | $160k | 99,484 | Feb 19, 2025 |
| Feb 14, 2025 | AARD Aardvark Therapeutics, Inc. | CConversion Series C Convertible Preferred Stockderivative | -59,332 | $0.00 | $0 | 0 | Feb 19, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.